Tivic Health Systems, Inc. (TIVC)

Ligand Pharmaceuticals Statistics

Total Valuation

TIVC has a market cap or net worth of $3.29 million. The enterprise value is $2.63 million.

Market Cap	3.29M
Enterprise Value	2.63M

Important Dates

The next confirmed earnings date is Thursday, August 14, 2025, after market close.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

TIVC has 1.04 million shares outstanding. The number of shares has increased by 535.59% in one year.

Current Share Class	1.04M
Shares Outstanding	1.04M
Shares Change (YoY)	+535.59%
Shares Change (QoQ)	+29.19%
Owned by Insiders (%)	0.12%
Owned by Institutions (%)	6.23%
Float	978,429

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.54
Forward PS	n/a
PB Ratio	0.74
P/TBV Ratio	4.07
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	5.09
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.70

Current Ratio	1.70
Quick Ratio	0.92
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -218.77% and return on invested capital (ROIC) is -128.99%.

Return on Equity (ROE)	-218.77%
Return on Assets (ROA)	-100.63%
Return on Invested Capital (ROIC)	-128.99%
Return on Capital Employed (ROCE)	-187.29%
Revenue Per Employee	$73,714
Profits Per Employee	-$810,857
Employee Count	7
Asset Turnover	0.15
Inventory Turnover	1.17

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -51.20% in the last 52 weeks. The beta is 1.98, so TIVC's price volatility has been higher than the market average.

Beta (5Y)	1.98
52-Week Price Change	-51.20%
50-Day Moving Average	3.88
200-Day Moving Average	4.58
Relative Strength Index (RSI)	32.67
Average Volume (20 Days)	32,014

Short Selling Information

The latest short interest is 25,452, so 2.45% of the outstanding shares have been sold short.

Short Interest	25,452
Short Previous Month	31,316
Short % of Shares Out	2.45%
Short % of Float	2.60%
Short Ratio (days to cover)	1.30

Income Statement

In the last 12 months, TIVC had revenue of $516,000 and -$5.68 million in losses. Loss per share was -$13.68.

Revenue	516,000
Gross Profit	-115,000
Operating Income	-5.69M
Pretax Income	-7.61M
Net Income	-5.68M
EBITDA	-5.68M
EBIT	-5.69M
Loss Per Share	-$13.68

Balance Sheet

The company has $669,000 in cash and n/a in debt, giving a net cash position of $669,000 or $0.64 per share.

Cash & Cash Equivalents	669,000
Total Debt	n/a
Net Cash	669,000
Net Cash Per Share	$0.64
Equity (Book Value)	3.04M
Book Value Per Share	4.30
Working Capital	520,000

Cash Flow

Operating Cash Flow	-4.95M
Capital Expenditures	n/a
Free Cash Flow	-4.95M
FCF Per Share	-$4.75

Margins

Gross Margin	-22.29%
Operating Margin	-1,101.94%
Pretax Margin	-1,100.00%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TIVC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-535.59%
Shareholder Yield	-535.59%
Earnings Yield	-172.30%
FCF Yield	-150.20%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on March 7, 2025. It was a reverse split with a ratio of 1:17.

Last Split Date	Mar 7, 2025
Split Type	Reverse
Split Ratio	1:17

Scores

TIVC has an Altman Z-Score of -19.5 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-19.5
Piotroski F-Score	1